We are live on ! Find out more
CKPT

Checkpoint Therapeutics
CKPT

Delisted

CKPT was delisted on the 29th of May, 2025.

Back to rankings

34 hedge funds and large institutions have $3.76M invested in Checkpoint Therapeutics in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 3 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

467% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 3

91% more call options, than puts

Call options by funds: $300K | Put options by funds: $157K

1.72% more ownership

Funds ownership: 22.2% → 23.92% (+1.7%)

15% less funds holding

Funds holding: 40 → 34 (-6)

36% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 11

84% less capital invested

Capital invested by funds: $23.4M → $3.76M (-$19.6M)

Holders
34
Holders Change
-6
Holders Change %
-15%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
17
Reduced
3
Closed
11
Calls
$300K
Puts
$157K
Net Calls
+$143K
Net Calls Change
-$197K

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$1.1M
2
CH
CVI Holdings
Delaware
+$732K
3
PAM
PVG Asset Management
Colorado
+$413K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$151K
5
BRWA
B. Riley Wealth Advisors
Florida
+$82.8K

Top Sellers

Rank Fund Capital Flow
1
TC
TwinBeech Capital
New York
-$14.3M
2
AC
Armistice Capital
New York
-$3.54M
3
Bank of America
Bank of America
North Carolina
-$1,000K
4
PAS
Park Avenue Securities
New York
-$238K
5
Millennium Management
Millennium Management
New York
-$188K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
26
Fidelity Investments
Massachusetts
$7.74K +$12.8K +2,552 +287%
Bank of America
27
Bank of America
North Carolina
$7.29K -$1,000K -199,218 -98%
Wells Fargo
28
Wells Fargo
California
$4.23K +$9.18K +1,829 +3,733%
UBS Group
29
UBS Group
Switzerland
$3.38K -$11.6K -2,303 -61%
TFGT
30
TS Financial Group (TSFG)
Illinois
$1K – – –
HGERS
31
Householder Group Estate & Retirement Specialist
Arizona
$1K +$1.51K +300 New
BAM
32
Belpointe Asset Management
Nevada
$191 – – –
FCA
33
Fortis Capital Advisors
Kansas
$117 – – –
AC
34
Armistice Capital
New York
– -$3.54M -691,895 Closed
TC
35
TwinBeech Capital
New York
– -$14.3M -113,152 Closed
PAS
36
Park Avenue Securities
New York
– -$238K -46,545 Closed
Millennium Management
37
Millennium Management
New York
– -$188K -36,878 Closed
Jane Street
38
Jane Street
New York
– -$51.3K -10,042 Closed
Group One Trading
39
Group One Trading
Illinois
– -$23.1K -4,602 Closed
TWM
40
Tradition Wealth Management
Minnesota
– -$4K -686 Closed
LAM
41
Lakewood Asset Management
Illinois
– -$3K -580 Closed
Rockefeller Capital Management
42
Rockefeller Capital Management
New York
– -$2K -529 Closed
Citadel Advisors
43
Citadel Advisors
Florida
– -$321 -64 Closed
FGAM
44
Financial Gravity Asset Management
Texas
– -$46 -5 Closed
1
2

CKPT Hedge Fund Activity: Q1 2023 in Review

34 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q1 2023, worth a combined $3.76M — down 84% from $23.4M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of CKPT and 7 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 17 added.

The largest buyer was Cowen and Company, opening a new position worth an estimated $1.1M. The largest seller was TwinBeech Capital, exiting entirely with an estimated $14.3M sold.

  • 34 institutional investors held Checkpoint Therapeutics (CKPT) as of Q1 2023, down from 40 in Q4 2022.
  • Funds reported $3.76M of Checkpoint Therapeutics stock for Q1 2023, down 84% quarter-over-quarter.
  • 7 funds opened new Checkpoint Therapeutics positions in Q1 2023 and 11 closed out, a net change of -4 holders.
  • The largest Checkpoint Therapeutics buyer in Q1 2023 was Cowen and Company, an estimated $1.1M added.
  • The largest Checkpoint Therapeutics seller in Q1 2023 was TwinBeech Capital, an estimated $14.3M sold.

Based on aggregated 13F filings for Q1 2023.